What are we paying for? A cost-effectiveness analysis of patented denosumab and generic alendronate for postmenopausal osteoporotic women in Australia

by Karnon, Jonathan, Shafie, Ainul Shakirah, Orji, Nneka, Usman, Sofoora Kawsar
Published 2016